RD06-05 CART Cell is named as an intervention in 4 current clinical trials in our China register. 2 are recruiting patients now. All registered phases are Phase EARLY_PHASE1. The sponsor with the most trials is Nanjing Bioheng Biotech Co., Ltd (2). The most-studied condition is SLE.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
NCT06775912 · ClinicalTrials.gov ↗ · SLE, Systemic Sclerosis, IIM
|
Phase EARLY_PHASE1 | Recruiting | Nanjing Bioheng Biotech Co., Ltd. | China |
|
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
NCT07203404 · ClinicalTrials.gov ↗ · SLE, LN, ANCA Associated Vasculitis
|
Phase EARLY_PHASE1 | Recruiting | Nanjing Bioheng Biotech Co., Ltd. | China |
|
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
NCT07309744 · ClinicalTrials.gov ↗ · Moderate-to-severe Ulcerative Colitis, Crohn's Disease (CD)
|
Phase EARLY_PHASE1 | Not yet open | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | China |
|
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
NCT07674147 · ClinicalTrials.gov ↗ · Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis
|
Phase EARLY_PHASE1 | Not yet open | The Children's Hospital of Zhejiang University School of Medicine | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| SLE | 2 |
| Systemic Sclerosis | 1 |
| IIM | 1 |
| NMOSD | 1 |
| Moderate-to-severe Ulcerative Colitis | 1 |
| Crohn's Disease (CD) | 1 |
| LN | 1 |
| ANCA Associated Vasculitis | 1 |
| ANCA-Associated Glomerulonephritis | 1 |
| Autoimmune Diseases | 1 |
| SLE - Systemic Lupus Erythematosus | 1 |
| SSc-Systemic Sclerosis | 1 |
| IIM- Idiopathic Inflammatory Myopathies | 1 |
| Lead sponsor | Trials |
|---|---|
| Nanjing Bioheng Biotech Co., Ltd. | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
| The Children's Hospital of Zhejiang University School of Medicine | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 4 | 2 |
A trial with sites in more than one country appears in each of those registers.
4 current trials in our China register name RD06-05 CART Cell as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 4 trials are recruiting: 2 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Nanjing Bioheng Biotech Co., Ltd (2), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) and The Children's Hospital of Zhejiang University School of Medicine (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how RD06-05 CART Cell works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how RD06-05 CART Cell works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists RD06-05 CART Cell (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.